Delivery Order SPE2DB22D2211-SPE2DB25FSEYF
- Not listed
- The Defense Logistics Agency awarded a $1,052.92 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 100 capsules of dextroamphetamine-amphetamine 30 mg on September 18, 2025, with completion scheduled for September 19, 2025. This competitive award, which carried no set-aside designation, represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through...
- The Defense Logistics Agency awarded a delivery order valued at $2,220.67 to AmerisourceBergen Drug Corp for 100 capsules of Dextroamphetamine-Amphetamine 30 mg on September 19, 2025, with an ultimate completion date of September 22, 2025. This firm fixed-price, non-set-aside delivery order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a small-value pharmaceutical procurement supporting federal medical supply needs...
- The Defense Logistics Agency awarded a delivery order valued at $1,127.41 to AmerisourceBergen Drug Corp for 100 capsules of Dextroamphetamine-Amphetamine 30 mg on September 11, 2025, with an ultimate completion date of September 12, 2025. This non-set-aside, competitively awarded contract utilized firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00...
- The Defense Logistics Agency awarded a delivery order valued at $1,170.56 to AmerisourceBergen Drug Corp for 100 capsules of dextroamphetamine-amphetamine 30 mg on September 16, 2025, with completion targeted for September 17, 2025. This competitively awarded, non-set-aside contract reflects a firm fixed price arrangement and represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The pharmaceutical products will be delivered to the company's...
- The Defense Logistics Agency awarded a $3,082.59 firm fixed price delivery order to AmerisourceBergen Drug Corp for 100 capsules of Dextroamphetamine-Amphetamine 30 mg on November 20, 2025, with an ultimate completion date of November 21, 2025. This non-set-aside contract represents a single delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product...
- The Defense Logistics Agency awarded a delivery order valued at $1,145.51 to AmerisourceBergen Drug Corp for 100 capsules of dextroamphetamine-amphetamine 10 mg, with performance at the company's Conshohocken, Pennsylvania facility. This firm fixed-price delivery order, awarded on November 17, 2025, represents a competitive award with no set-aside designation and carries an ultimate completion date of November 18, 2025. The contract falls under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,258.76 to AmerisourceBergen Drug Corp for 100 capsules of Dextroamphetamine-Amphetamine 20 mg on January 9, 2026, with an ultimate completion date of January 12, 2026. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a major...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,487.10 to AmerisourceBergen Drug Corp for 100 capsules of dextroamphetamine-amphetamine 20 mg. This competitively awarded, firm fixed-price delivery order was issued on December 16, 2025, with an ultimate completion date of December 17, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for 100 capsules of Dextroamphetamine-Amphetamine 25 mg, valued at $1,169.78. The award was made on July 31, 2025, with an ultimate completion date of August 1, 2025. This non-set-aside, competitively awarded delivery order employs firm fixed-price pricing and represents a direct fulfillment of pharmaceutical supply needs for federal military healthcare operations....
- The Defense Logistics Agency awarded a $1,387.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of dextroamphetamine-amphetamine 30 mg capsules (100-count units). This is a non-set-aside competitive award with an ultimate completion date of December 16, 2025, and performance is based in Conshohocken, Pennsylvania, the company's headquarters location. The delivery order falls under AmerisourceBergen's broader Indefinite Delivery Contract...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSEYFDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,441.52 to AmerisourceBergen Drug Corp for 100 capsules of Dextroamphetamine-Amphetamine 30 mg. This firm fixed-price, competitively awarded delivery order was issued on September 15, 2025, with an ultimate completion date of September 16, 2025. The pharmaceutical product will be sourced from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical supply vehicle for military healthcare programs. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive portfolio of federal contract awards demonstrates its capability to supply a wide range of pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. As the prime contractor on this delivery order with no set-aside designation, AmerisourceBergen continues to fulfill essential medical supply requirements for military and veteran healthcare systems through its competitive relationship with the Defense Logistics Agency.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 9/15/25 |